Although no previous studies have analyzed the effect of ERK1 deficiency on atherosclerosis in vivo, pharmacological inhibition of ERK1/2 and activation of LXR was found to synergistically decrease atherosclerotic lesions in ApoE−/− mice.41 The gene discussed is MAPK3; the disease is atherosclerosis.